Intensity Therapeutics, Inc.
INTS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001567264
No open-market purchases or sales by Intensity Therapeutics, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $4.79M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Intensity Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 26 | 35 | +9 |
| Shares | 2.96M | 3.92M | +957.6K (+32.3%) |
| Value | $721.2K | $1.58M | +$862.9K (+119.6%) |
New holders (10)
Institutions that held Intensity Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Legacy Advisors, LLC | 153,447 | $62.9K | 0.01% |
| Creative Planning | 143,136 | $58.7K | 0.00% |
| CI Private Wealth, LLC | 100,000 | $41.0K | 0.00% |
| Jane Street Group, LLC | 62,755 | $25.7K | 0.00% |
| GWM Advisors LLC | 25,000 | $10.3K | 0.00% |
| Marex Group plc | 15,000 | $6.15K | 0.00% |
| T3 Companies, LLC | 13,600 | $5.58K | 0.01% |
| Vontobel Holding Ltd. | 12,000 | $4.86K | 0.00% |
| Beacon Pointe Advisors, LLC | 10,199 | $4.18K | 0.00% |
| Pensionmark Financial Group, LLC | 10,000 | $4.10K | 0.00% |
Sold out (1)
Institutions that held Intensity Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Scientech Research LLC | 24,726 | $6.00K |